薬学および生命科学における研究開発の国際ジャーナル

抽象的な

Pharmacovigilance and Clinical Safety: Comparison between India, US and Europe-A Review

Dr. Amirtha Tom, Rhea Joseph, Priyanka Pingat, Dr.Harinarayanan

Pharmacovigilance (PV) is a crucial component of the system for regulating pharmaceuticals. PV is essential for the detection, evaluation, and dissemination of adverse drug reactions (ADRs) using a variety of channels. ADRs cause significant harm to patients and can possibly increase morbidity and mortality. The public health safety and promotion of responsible drug use are both aided by the PV databases. In order to broaden the scope of the current PV structure in India, this essay analyzes the PV systems in the USA, Europe, and India while underlining the difficulties and potential solutions. In comparison to other nations, PV schemes in India are still in their infancy.